{"result": {"id": "75d9f75e-2c9b-4869-84c5-7f881aeba335", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>秋水仙碱<|>organization<|>秋水仙碱是一种用于治疗痛风急性发作的药物，建议在发作12小时内开始使用，超过36小时效果下降。需根据肾功能调整剂量，可能出现胃肠道不良反应及肝、肾损害。\")\n##\n(\"entity\"<|>非甾体抗炎药<|>organization<|>非甾体抗炎药是痛风急性发作的常用药物，包括非特异性COX抑制剂和特异性COX-2抑制剂，需注意胃肠道和心血管风险。\")\n##\n(\"entity\"<|>糖皮质激素<|>organization<|>糖皮质激素主要用于急性痛风发作伴全身症状或其他药物无效时，推荐短期使用，需注意高血压等副作用。\")\n##\n(\"entity\"<|>IL-1受体拮抗剂<|>organization<|>IL-1受体拮抗剂可作为二线痛风急性发作期的治疗药物，适用于对一线药物不耐受或有禁忌的患者。\")\n##\n(\"relationship\"<|>秋水仙碱<|>非甾体抗炎药<|>秋水仙碱和非甾体抗炎药均为痛风急性发作的一线治疗药物，可单独或联合使用。<|>7)\n##\n(\"relationship\"<|>糖皮质激素<|>秋水仙碱<|>糖皮质激素用于秋水仙碱无效或使用禁忌的患者。<|>6)\n##\n(\"relationship\"<|>糖皮质激素<|>非甾体抗炎药<|>糖皮质激素用于非甾体抗炎药无效或使用禁忌的患者。<|>6)\n##\n(\"relationship\"<|>IL-1受体拮抗剂<|>秋水仙碱<|>IL-1受体拮抗剂可作为秋水仙碱不耐受或有禁忌时的二线治疗药物。<|>5)\n##\n(\"relationship\"<|>IL-1受体拮抗剂<|>非甾体抗炎药<|>IL-1受体拮抗剂可作为非甾体抗炎药不耐受或有禁忌时的二线治疗药物。<|>5)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165305, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 444, "prompt_tokens": 2522, "total_tokens": 2966, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 0}, "prompt_cache_hit_tokens": 0, "prompt_cache_miss_tokens": 2522}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 炎治  疗 。若单药治疗效果不佳，可选择上述药物联合治  疗 。对上述药物不耐受或有禁忌时，国外亦有使用  白细胞介素（IL）?1 受体拮抗剂作为二线痛风急性  发作期的治疗 。 目前无证据支持弱阿片类、阿片类  止痛药物对痛风急性发作有效。\n　　　1. 秋水仙碱：建议应用低剂量秋水仙碱，首剂  1 mg，1  h 后 增 加 0.5 mg，12  h 后 按 照 0.5 mg，1~  3 次/d 。最宜在痛风急性发作 12 h 内开始用药，超  过 36 h 效果明显下降 。 当 eGFR 为 30~60 ml/min  时 ，秋 水 仙 碱 最 大 剂 量 0.5 mg/d；eGFR 为 15~  30 ml/min 时 ，秋 水 仙 碱 最 大 剂 量 每 两 天 0.5 mg； eGFR<15 ml/min 者或透析患者禁用 。该药可能出  现胃肠道不良反应，如腹泻、腹痛、恶心、呕吐，同时  可能出现肝、肾损害及骨髓抑制，应定期监测肝肾  功 能 及 血 常 规 。 使 用 强 效  P?糖 蛋 白 和/或  CYP3A4 抑制剂（如环孢素 A 或克拉霉素）的患者禁  用秋水仙碱。\n\n\n　　　2. 非甾体抗炎药：痛风急性发作应尽早应用足 量非甾体抗炎药的速效剂型，主要包括非特异性环 氧化酶（COX）抑制剂和特异性 COX?2 抑制剂 。非 特异性 COX 抑制剂需注意消化道溃疡、出血、穿孔 等胃肠道风险；特异性 COX?2 抑制剂的胃肠道风险 较非特异性 COX 抑制剂降低 50% 左右，但活动性 消化道出血、穿孔仍是用药禁忌 。此外，非甾体抗 炎药亦可出现肾损害，注意监测肾功能；肾功能异 常者应充分水化，并监测肾功能，eGFR<30 ml/min 且未行透析者不宜使用 。特异性 COX?2 抑制剂亦 可能增加心血管事件发生风险，高风险人群应用须 谨慎 。常用非甾体抗炎药见表 2。\n　　　3. 糖皮质激素：主要用于急性痛风发作伴全身 症状 、或秋水仙碱和非甾体抗炎药无效或使用禁 忌 、或 肾 功 能 不 全 者 。一 般 推 荐 泼 尼 松 0.5 mg · kg-1 ·d-1 连续用药 5~ 10 d 停药，或用药 2~5 d 后逐渐 减量，总疗程 7~ 10 d，不宜长期使用 。若痛风急性 发作累及大关节时，或口服治疗效果差，可给予关 节腔内或肌肉注射糖皮质激素，如复方倍他米松和 曲安奈德，但需排除关节感染，并避免短期内反复 注射 。应用糖皮质激素注意高血压、高\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_e933ed3f0ea8937697e124941718433313d0d4ba5653e849925821a6bb296a6a_v2"}